TEKLA CAPITAL MANAGEMENT LLC Fate Therapeutics, Inc. Transaction History

TEKLA CAPITAL MANAGEMENT LLC portfolio value:

$0
portfolio value

TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:

-9.56%
quarter

Fate Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -31.65K shares -784K $22.41 0
Q2 2022 share 0.00% 0 shares -443K $24.78 31.65K
Q1 2022 share Decrease -56.48% -41.07K shares -3.02M $38.77 31.65K
Q4 2021 share 0.00% 0 shares -56K $60.07 72.72K
Q3 2021 share 0.00% 0 shares -2.00M $59.27 72.72K
Q2 2021 share Decrease -51.63% -77.61K shares -6.08M $86.79 72.72K
Q1 2021 share Decrease -9.60% -15.97K shares -2.72M $82.45 150.34K
Q4 2020 share Decrease -23.52% -51.14K shares 6.43M $90.93 166.31K
Q3 2020 share Increase +17.12% 31.79K shares 2.32M $39.97 217.46K
Q2 2020 share Increase +12.07% 20K shares 2.69M $34.31 185.67K
Q1 2020 share 0.00% 0 shares 438K $22.21 165.67K
Q4 2019 share 0.00% 0 shares 669K $19.57 165.67K
Q3 2019 share Increase +579.57% 141.29K shares 2.07M $15.53 165.67K
Q2 2019 share Increase 0.00% 24.37K shares 495K $20.3 24.37K